User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.67% 147.50 145.00 150.00 149.50 147.50 149.50 68,911 16:09:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 84

ReNeuron Group plc Holding(s) in Company

16/03/2021 6:57pm

UK Regulatory (RNS & others)


TIDMRENE

RNS Number : 4232S

ReNeuron Group plc

16 March 2021

TR-1: S tandard form for notification of major holdings

 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
 to the FCA in Microsoft Word format if possible) (i) 
 
1a. Identity of the issuer or the                         ReNeuron Group plc 
 underlying issuer of existing shares 
 to which voting rights are attached 
 (ii) : 
1b. Please indicate if the issuer is a non-UK issuer (please mark with 
 an "X" if appropriate) 
Non-UK issuer 
2. Reason for the notification (please mark the appropriate box or boxes 
 with an "X") 
An acquisition or disposal of voting rights                                                     X 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights 
Other (please specify)(iii) : 
3. Details of person subject to the notification obligation (iv) 
Name                                                      Rosetta Capital VI GP LP, on behalf 
                                                           of Rosetta Capital VI, LP 
City and country of registered office                     London, United Kingdom 
 (if applicable) 
4. Full name of shareholder(s) (if different from 3.) (v) 
Name 
City and country of registered office 
 (if applicable) 
5. Date on which the threshold was                        15 March 2021 
 crossed or reached (vi) : 
6. Date on which issuer notified (DD/MM/YYYY):            15 March 2021 
7. Total positions of person(s) subject to the notification obligation 
                         % of voting        % of voting rights    Total of both  Total number 
                          rights attached    through financial     in % (8.A +    of voting rights 
                          to shares (total   instruments           8.B)           of issuer (vii) 
                          of 8. A)           (total of 8.B 
                                             1 + 8.B 2) 
Resulting situation 
 on the date 
 on which threshold 
 was crossed 
 or reached              5.6635%            N/A                   5.6635%          56,855,705 
Position of              N/A                N/A                   N/A 
 previous notification 
 (if 
 applicable) 
 
 
 
8. Notified details of the resulting situation on the date on which 
 the threshold was crossed or reached (viii) 
A: Voting rights attached to shares 
Class/type of       Number of voting rights                             % of voting rights 
 shares              (ix) 
 ISIN code (if 
 possible) 
                    Direct                  Indirect                    Direct                    Indirect 
                     (Art 9 of Directive     (Art 10 of Directive        (Art 9 of Directive      (Art 10 of Directive 
                     2004/109/EC)            2004/109/EC)                2004/109/EC) (DTR5.1)    2004/109/EC) 
                     (DTR5.1)                (DTR5.2.1)                                           (DTR5.2.1) 
GB00BF5G6K95        3,219,519                                           5.6635% 
 
 
SUBTOTAL 8. A       3,219,519                                           5.6635% 
 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
 (DTR5.3.1.1 (a)) 
Type of financial   Expiration    Exercise/                      Number of voting                 % of voting 
 instrument          date (x)      Conversion Period              rights that may                  rights 
                                   (xi)                           be acquired if 
                                                                  the instrument 
                                                                  is 
                                                                  exercised/converted. 
 
 
 
                                  SUBTOTAL 8. B 1 
 
B 2: Financial Instruments with similar economic effect according to 
 Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
Type of        Expiration         Exercise/            Physical or           Number of            % of voting 
 financial      date (x)           Conversion           cash                  voting rights        rights 
 instrument                        Period (xi)          settlement 
                                                        (xii) 
 
 
 
                                                       SUBTOTAL 8.B.2 
 
 
 
 
9. Information in relation to the person subject to the notification 
 obligation (please mark the 
 applicable box with an "X") 
Person subject to the notification obligation is not controlled 
 by any natural person or legal entity and does not control any other 
 undertaking(s) holding directly or indirectly an interest in the 
 (underlying) issuer (xiii) 
Full chain of controlled undertakings through which the voting rights                 X 
 and/or the 
 financial instruments are effectively held starting with the ultimate 
 controlling natural person or legal entity (xiv) (please add additional 
 rows as necessary) 
Name (xv)             % of voting rights     % of voting rights    Total of both if 
                       if it equals or        through financial     it equals or is 
                       is higher than the     instruments if it     higher than the 
                       notifiable threshold   equals or is higher   notifiable threshold 
                                              than the notifiable 
                                              threshold 
Rosetta Capital 
 VI GP LP on behalf 
 of Rosetta Capital 
 VI, LP               5.6635%                N/A                   5.6635% 
 
 
 
 
 
10. In case of proxy voting, please identify: 
Name of the proxy holder 
The number and % of voting rights 
 held 
The date until which the voting rights 
 will be held 
 
11. Additional information (xvi) 
 
 
 
 
Place of completion  London 
Date of completion   15 March 2021 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLEAEDKFSDFEFA

(END) Dow Jones Newswires

March 16, 2021 14:57 ET (18:57 GMT)

1 Year Reneuron Chart

1 Year Reneuron Chart

1 Month Reneuron Chart

1 Month Reneuron Chart
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210509 18:45:45